Also, the conolidine molecule didn't interact with the classical receptors, this means that it wouldn't compete versus opioid peptides to bind to these receptors.In 2011, the Bohn lab pointed out antinociception from both equally chemically induced and inflammation-derived soreness, and experiments indicated lack of opioid receptor modulation, but